Valiant Co.,Ltd (002643.SZ) reported earnings for nine months that Dropped, from last year
The company's earnings came in at RMB268.51 million, or RMB0.29 per share. This compares with RMB305.63 million, or RMB0.33 per share, last year.
The company's revenue for the period rose 4.7% to RMB2.958 billion from RMB2.826 billion last year.
Valiant Co.,Ltd earnings at a glance (GAAP) :
-Earnings: RMB268.51 Mln. vs. RMB305.63 Mln. last year.-EPS: RMB0.29 vs. RMB0.33 last year.-Revenue: RMB2.958 Bln vs. RMB2.826 Bln last year.
For comments and feedback contact: [email protected]
Business News
October 27, 2026 07:42 ET November brings a new lineup of FDA regulatory milestones that could influence biotech stocks. This video highlights five biotech companies to watch ahead of their upcoming FDA decisions, spanning potential treatments for sickle cell disease, psychiatric disorders, cardiovascular conditions, and cancer.